停止定期,低剂量,持续释放吗啡的主观经验,当治疗中度至重度慢性呼吸不良时
David Currow1, Sungwon Chang2, Belinda Fazekas2
1College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
Journal of palliative medicine
|December 31, 2025
概括
这项研究发现,与安慰剂相比,治疗慢性喘息的短期低剂量吗啡并没有显著增加阿片类药物戒断症状. 临床医生可以利用这些发现与患者讨论风险.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 抚慰性护理是一种缓解性护理.
- 临床药理学 临床药理学
背景情况:
- 慢性喘息严重影响COPD患者的生活质量.
- 低剂量,持续释放的吗啡正在研究慢性呼吸不良,但戒断风险令人担忧.
- 时间有限的试验被用来评估吗啡的疗效和安全性.
研究的目的:
- 评估COPD患者中断低剂量持续释放吗啡后阿片类药物戒断症状的发生率.
- 为了比较吗啡和安慰剂组之间的戒断症状.
- 评估吗啡剂量和持续时间对戒断症状的影响.
主要方法:
- 一项随机,安慰剂控制,双盲试验的子研究,涉及中度至重度呼吸困难的COPD患者 (mMRC 3-4).
- 参与者接受了剂量定位阶段 (≤3周) 和盲目的延长阶段 (<26周).
- 主观阿片类药物戒断量表 (SOWS) 在戒断后的三天内每天给药;得分>20/60表明戒断严重.
主要成果:
- 在停药后的1-3天内,吗啡和安慰剂组之间的SOWS得分没有统计学上显著的差异.
- 吗啡剂量和持续时间没有显著影响戒断症状得分.
- 低剂量组的两名参与者报告了所有三天的得分>20;常见的戒断症状包括焦虑,鼻,汗水,,发热和恶心.
结论:
- 短期,低剂量持续释放的吗啡用于慢性COPD呼吸困难似乎不会引起显著的阿片类药物戒断症状.
- 临床上显著的戒断风险似乎很低,为患者和临床医生的讨论提供了信息.
- 像SOWS这样的验证工具对于量化自我报告的戒断症状至关重要.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
875
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
875
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Morphine and Other Natural Cogeners
797
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
797
COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K


